scispace - formally typeset
I

Isamu Hoshino

Researcher at Chiba University

Publications -  121
Citations -  2573

Isamu Hoshino is an academic researcher from Chiba University. The author has contributed to research in topics: Cancer & Esophageal cancer. The author has an hindex of 24, co-authored 110 publications receiving 2182 citations. Previous affiliations of Isamu Hoshino include Michigan State University.

Papers
More filters
Journal ArticleDOI

Prognostic significance of p16 protein in pancreatic ductal adenocarcinoma.

TL;DR: The relationship between the expression levels of p16 and the clinicopathological features associated with prognosis in patients with primary pancreatic ductal adenocarcinomas was evaluated and negative p16 expression on IHC was not significantly associated with poor prognosis.
Journal ArticleDOI

A case of small-cell esophageal cancer with chronic renal failure undergoing hemodialysis safely treated with cisplatin and etoposide

TL;DR: A 54-year-old male undergoing hemodialysis was admitted to the authors' hospital because of difficulty in swallowing and diagnosed as a small-cell esophageal cancer, which showed a tumor infiltrating the trachea and a few lymph node metastases in the cervix, upper mediastinum, and abdomen.
Journal ArticleDOI

Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma.

TL;DR: The high miR-1246/miR-106b ratio group was associated with clinicopathological factors such as depth of invasion, progression, lymph node metastasis, and poor prognosis, therefore, effective biomarkers may be generated by combining individual miRs obtained by comprehensive analysis of ESCC patient sera.
Journal ArticleDOI

Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma.

TL;DR: In this paper, the authors investigated the usefulness of microRNA (miR)-1246 detection in various body fluids as a biomarker for esophageal squamous cell carcinoma.
Journal ArticleDOI

Prevalence of autoantibodies against Ras‑like GTPases, RalA, in patients with gastric cancer

TL;DR: In this paper, the authors investigated the clinical significance of serum RalA antibody in patients with gastric cancer and found that the presence of s-RalA-abs, in combination with CEA and/or CA19-9, was associated with poor survival.